Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan

Akemi Tomoda; Keiko Nomura; Seiji Shiraishi; Akinobu Hamada; Takafumi Ohmura; Mitsuaki Hosoya; Teruhisa Miike; Yukio Sawaishi; Hiroshi Kimura; Hiroshi Takashima; Yoshihiro Tohda; Kenji Mori; Zenichiro Kato; Ai Fukushima; Hisanori Nishio; Akio Nezu; Kenji Nihei

doi:10.1016/S0387-7604(03)00062-7

Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan

Akemi Tomoda, Keiko Nomura, Seiji Shiraishi, Akinobu Hamada, Takafumi Ohmura, Mitsuaki Hosoya, Teruhisa Miike, Yukio Sawaishi, Hiroshi Kimura, Hiroshi Takashima, Yoshihiro Tohda, Kenji Mori, Zenichiro Kato, Ai Fukushima, Hisanori Nishio, Akio Nezu, Kenji Nihei

Pediatrics

Research output: Contribution to journal › Article › peer-review

20 Citations (Scopus)

Abstract

Ten patients with SSPE were surveyed during the last 4 years from the viewpoint of clinical safety for use of ribavirin therapy. Although effectiveness varied among cases, they were all treated safely with intraventricular ribavirin. This study suggests that treatment is safe and well-tolerated.

Original language	English
Pages (from-to)	514-517
Number of pages	4
Journal	Brain and Development
Volume	25
Issue number	7
DOIs	https://doi.org/10.1016/S0387-7604(03)00062-7
Publication status	Published - Oct 2003

All Science Journal Classification (ASJC) codes

Pediatrics, Perinatology, and Child Health
Developmental Neuroscience
Clinical Neurology

Access to Document

10.1016/S0387-7604(03)00062-7

Cite this

Tomoda, A., Nomura, K., Shiraishi, S., Hamada, A., Ohmura, T., Hosoya, M., Miike, T., Sawaishi, Y., Kimura, H., Takashima, H., Tohda, Y., Mori, K., Kato, Z., Fukushima, A., Nishio, H., Nezu, A., & Nihei, K. (2003). Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan. Brain and Development, 25(7), 514-517. https://doi.org/10.1016/S0387-7604(03)00062-7

Tomoda, A, Nomura, K, Shiraishi, S, Hamada, A, Ohmura, T, Hosoya, M, Miike, T, Sawaishi, Y, Kimura, H, Takashima, H, Tohda, Y, Mori, K, Kato, Z, Fukushima, A, Nishio, H, Nezu, A & Nihei, K 2003, 'Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan', Brain and Development, vol. 25, no. 7, pp. 514-517. https://doi.org/10.1016/S0387-7604(03)00062-7

@article{be50a290dbfc40df808e55439026f74d,

title = "Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan",

abstract = "Ten patients with SSPE were surveyed during the last 4 years from the viewpoint of clinical safety for use of ribavirin therapy. Although effectiveness varied among cases, they were all treated safely with intraventricular ribavirin. This study suggests that treatment is safe and well-tolerated.",

author = "Akemi Tomoda and Keiko Nomura and Seiji Shiraishi and Akinobu Hamada and Takafumi Ohmura and Mitsuaki Hosoya and Teruhisa Miike and Yukio Sawaishi and Hiroshi Kimura and Hiroshi Takashima and Yoshihiro Tohda and Kenji Mori and Zenichiro Kato and Ai Fukushima and Hisanori Nishio and Akio Nezu and Kenji Nihei",

year = "2003",

month = oct,

doi = "10.1016/S0387-7604(03)00062-7",

language = "English",

volume = "25",

pages = "514--517",

journal = "Brain and Development",

issn = "0387-7604",

publisher = "Elsevier",

number = "7",

}

TY - JOUR

T1 - Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan

AU - Tomoda, Akemi

AU - Nomura, Keiko

AU - Shiraishi, Seiji

AU - Hamada, Akinobu

AU - Ohmura, Takafumi

AU - Hosoya, Mitsuaki

AU - Miike, Teruhisa

AU - Sawaishi, Yukio

AU - Kimura, Hiroshi

AU - Takashima, Hiroshi

AU - Tohda, Yoshihiro

AU - Mori, Kenji

AU - Kato, Zenichiro

AU - Fukushima, Ai

AU - Nishio, Hisanori

AU - Nezu, Akio

AU - Nihei, Kenji

PY - 2003/10

Y1 - 2003/10

N2 - Ten patients with SSPE were surveyed during the last 4 years from the viewpoint of clinical safety for use of ribavirin therapy. Although effectiveness varied among cases, they were all treated safely with intraventricular ribavirin. This study suggests that treatment is safe and well-tolerated.

AB - Ten patients with SSPE were surveyed during the last 4 years from the viewpoint of clinical safety for use of ribavirin therapy. Although effectiveness varied among cases, they were all treated safely with intraventricular ribavirin. This study suggests that treatment is safe and well-tolerated.

UR - http://www.scopus.com/inward/record.url?scp=0344873620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344873620&partnerID=8YFLogxK

U2 - 10.1016/S0387-7604(03)00062-7

DO - 10.1016/S0387-7604(03)00062-7

M3 - Article

C2 - 13129596

AN - SCOPUS:0344873620

SN - 0387-7604

VL - 25

SP - 514

EP - 517

JO - Brain and Development

JF - Brain and Development

IS - 7

ER -

Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this